LUT Innervation - The Plumbing Pilots
- Storage Phase (Filling): Sympathetic Dominance
- Bladder (Detrusor): Relaxed via $\beta_3$ adrenergic receptors.
- Bladder Neck & Proximal Urethra: Contracted via $\alpha_1$ adrenergic receptors.
- Somatic (Pudendal n.): External urethral sphincter contracted.
- Voiding Phase (Micturition): Parasympathetic Dominance
- Bladder (Detrusor): Contracts via $M_3$ muscarinic receptors.
- Bladder Neck & Proximal Urethra: Relaxed (inhibition of $\alpha_1$ tone).
- Somatic: External urethral sphincter relaxes.

⭐ The predominant muscarinic receptor subtype in the human detrusor muscle is $M_3$, with $M_2$ being more numerous but $M_3$ mediating contraction primarily. (NEET PG Favourite)
📌 Storage = Sympathetic; Peeing = Parasympathetic
Overactive Bladder Tx - Urge Under Arrest
Manages urgency, frequency, urge incontinence. 📌 "Urge Under Arrest"
-
1st Line: Behavioral (bladder training, Kegels).
-
2nd Line: Pharmacotherapy
- Antimuscarinics (M3 blockers): Relax detrusor.
- Oxybutynin (⚠️ caution elderly: cognitive SEs), Tolterodine.
- M3 Selective: Solifenacin, Darifenacin (↓ SEs).
- Trospium (quaternary: ↓ CNS SEs).
- Common SEs: Dry mouth, constipation, blurred vision.
- Beta-3 Agonists: Relax detrusor, ↑ capacity.
- Mirabegron (monitor BP: can ↑ HTN).
- Vibegron (newer, potentially fewer BP effects).
- Fewer anticholinergic SEs vs. antimuscarinics.
- Antimuscarinics (M3 blockers): Relax detrusor.
-
3rd Line: Botox, PTNS, Sacral Neuromodulation.
⭐ Mirabegron is a preferred option for OAB patients intolerant to antimuscarinic side effects or where cognitive impairment is a concern.
BPH & Retention Tx - Go With the Flow
- BPH (Lower Urinary Tract Symptoms - LUTS):
- α1-Blockers (Dynamic Relief): Rapid action. Relax prostatic & bladder neck smooth muscle.
- Prazosin, Terazosin, Doxazosin (α1-selective): Risk of first-dose hypotension, postural dizziness.
- Tamsulosin, Silodosin (α1A/α1D uroselective): Fewer systemic BP effects; risk of ejaculatory dysfunction.
- 📌 Mnemonic: "Sins" of the prostate (Tamsulosin, Silodosin, Doxazosin, Prazosin).
- 5α-Reductase Inhibitors (Static Relief): Reduce prostate size by blocking Testosterone → Dihydrotestosterone (DHT).
- Finasteride, Dutasteride.
- Slow onset (3-6 months). Side effects: ↓ libido, erectile dysfunction.
- Combination therapy (α1-blocker + 5ARI) for significant LUTS & enlarged prostate.
- α1-Blockers (Dynamic Relief): Rapid action. Relax prostatic & bladder neck smooth muscle.
- Urinary Retention (Non-Obstructive Atonic Bladder):
- Cholinomimetics (Muscarinic Agonists):
- Bethanechol: Stimulates M3 receptors on detrusor muscle, promoting bladder contraction.
- Uses: Post-operative, post-partum urinary retention; neurogenic bladder.
- ⚠️ Contraindications: Mechanical obstruction, asthma, peptic ulcer disease, bradycardia.
- Cholinomimetics (Muscarinic Agonists):
⭐ Uroselective α1A-blockers like Tamsulosin are preferred for BPH in normotensive patients; Silodosin has highest ejaculatory dysfunction risk.
Other Uses & Cautions - Tricky Waters
- Stress Urinary Incontinence (SUI):
- Alpha-agonists (Midodrine): ↑ urethral tone.
- Duloxetine (SNRI): ↑ pudendal nerve activity.
- Neurogenic Bladder:
- Anticholinergics for overactivity.
- Alpha-blockers for outlet obstruction.
- Nocturnal Enuresis: Imipramine.
- Key Cautions:
- Alpha-blockers: Postural hypotension. ⚠️ Tamsulosin: Intraoperative Floppy Iris Syndrome (IFIS).
- Anticholinergics: Dry mouth, constipation, blurred vision, cognitive issues (elderly), urinary retention risk in BPH.
- Mirabegron: May ↑ BP.
⭐ Tamsulosin is notorious for causing Intraoperative Floppy Iris Syndrome (IFIS), a crucial consideration before cataract surgery.
High‑Yield Points - ⚡ Biggest Takeaways
- BPH: α1-blockers for rapid symptom relief; 5α-reductase inhibitors for prostate size reduction.
- OAB: Antimuscarinics (e.g., Oxybutynin) are first-line; Mirabegron (β3-agonist) is an alternative.
- Urinary Retention: Bethanechol (muscarinic agonist) for non-obstructive, often post-operative, retention.
- Tamsulosin: Uroselective α1A/α1D blocker, less hypotension.
- Finasteride: Inhibits 5α-reductase, ↓DHT, shrinks prostate.
- Antimuscarinic ADRs: Dry mouth, blurred vision, constipation, cognitive issues (elderly).
- Mirabegron: β3-agonist for OAB, can ↑BP_._
Continue reading on Oncourse
Sign up for free to access the full lesson, plus unlimited questions, flashcards, AI-powered notes, and more.
CONTINUE READING — FREEor get the app